The congress takes place 2025 in Rome, Italy, from June 5 – 7.
The most important aspect of this congress is bridging science, innovation, and patient care with the focus on heart health.
The scientific sessions bring together experts from the fields of basic research, translational medicine, pharma R&D, and patient care in order to help to improve cardiovascular outcomes.
Relaxera’s CEO and chairman Thomas Bernd Dschietzig is member of the scientific committee and gives a keynote presentation about “The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF”.
The full conference program you can find here.
Venue Address:
NH Villa Carpegna
Via Pio IV, 6, 00165 Roma RM, Italy